COVID-19 Impact on RSV Emergency Presentations — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

COVID-19 Impact on RSV Emergency Presentations — Stella

Recruiting

Back to Bronchiolitis; Respiratory Syncytial Virus trials

Trial locations(1 site)

United Kingdom

University Hospitals of Leicester NHS Trust, Leicester

Key details

Sponsor

University Hospitals, Leicester

Collaborators

Respiratory syncytial virus consortium in Europe, Pediatric Emergency Research in the UK and Ireland (PERUKI)

Enrollment target

~3,000 participants

Started

June 2021

Primary completion

March 2026

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

0 Years – 2 Years

Last updated January 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov